Erin Mauney: Psychedelics as modulators of the gut-brain interaction
Psychedelics · 2025
DOI: 10.61373/pp025k.0020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychedelics, 2025. Verfasst von Erin E. Mauney. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dr. Erin E. Mauney serves as Assistant Professor of Pediatrics (Gastroenterology) at Tufts University while maintaining a research appointment at Massachusetts General Hospital. With dual board certification, including obesity medicine, she integrates clinical expertise with innovative research at the intersection of gut-brain disorders and psychedelic medicine. Dr. Mauney's groundbreaking work explores how psilocybin modulates interoception in treatment-resistant IBS, the first study of its kind in gastroenterology. In this Genomic Press Interview, she articulates how early-life trauma becomes somatically encoded and how psychedelic-assisted therapy creates pathways for emotional release and functional improvement. Her patient-centered approach combines neuroimaging, qualitative analysis, and clinical outcomes to develop scalable therapeutic options that challenge the artificial mind-body divide in contemporary medicine. Dr. Mauney's research represents a paradigm shift in understanding how psychedelics may transform treatment for the significant population of patients who remain unresponsive to conventional therapies.
Zitieren
APA
Mauney, E. E. (2025). Erin Mauney: Psychedelics as modulators of the gut-brain interaction. Psychedelics. https://doi.org/10.61373/pp025k.0020
Vancouver
Mauney EE. Erin Mauney: Psychedelics as modulators of the gut-brain interaction. Psychedelics. 2025. doi:10.61373/pp025k.0020
BibTeX
@article{Mauney2025,
author = {Mauney, Erin E.},
title = {Erin Mauney: Psychedelics as modulators of the gut-brain interaction},
journal = {Psychedelics},
year = {2025},
doi = {10.61373/pp025k.0020}
}
EUVIMED